A review of the totality of evidence supporting the development and approval of a pegfilgrastim biosimilar (LA-EP2006).
Agarwala SS, Nagl U, Guo X, Bellon A, Heyn J, Dimova-Dobreva M, Shen YM, Schaffar G, Humphrey M, Mathieson N, Koptelova N, Gattu S.
Agarwala SS, et al. Among authors: heyn j.
Curr Med Res Opin. 2022 Jun;38(6):999-1009. doi: 10.1080/03007995.2022.2061707. Epub 2022 Apr 17.
Curr Med Res Opin. 2022.
PMID: 35392751
Free article.
Review.